Vimta Labs Limited provides contract research and testing services in India and internationally. The company offers drug discovery, development, and drug life cycle management support services in the areas of preclinical research, clinical research, and analytical services for biopharmaceutical companies; preclinical research and testing services for medical device companies; and contract research and testing for agrochemical and specialty chemical companies. It also provides food testing and analytical development services to support manufacturers, processors, farmers, retailers, traders, exporters, and regulators; and a testing laboratory for water, alcoholic, and non-alcoholic beverages. In addition, the company offers environmental regulatory services, such as impact assessments and post project monitoring, to various industries, including power, infrastructure, cement, oil and gas, and mining, etc.; and EMI/EMC testing for electronic and electrical products/components. It provides
| Current Price | ₹469.00 |
|---|---|
| Market Cap | ₹2,095 Cr |
| Sector | Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services |
| Sub-Industry | Life Sciences Tools and Services |
| P/E Ratio | 27.3 |
| Return on Equity | 18.55% |
| 52-Week Range | ₹376.05 – ₹902.65 |
| Beta (1Y) | 0.78 |
| Dividend Yield | 0.43% |
1. Contract Research and Testing Services-100%
Vimta Labs Ltd is trading at ₹469.00, with a market capitalisation of ₹2,095 Cr.
Vimta Labs Ltd operates in the Health Care > Pharmaceuticals, Biotechnology and Life Sciences > Life Sciences Tools and Services space (Life Sciences Tools and Services).
Vimta Labs Ltd has a P/E of 27.3 and a return on equity of 18.55%.